SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-049237
Filing Date
2019-09-11
Accepted
2019-09-11 20:09:04
Documents
1
Period of Report
2019-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5174
  Complete submission text file 0001209191-19-049237.txt   6865
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O BIOTRANSPLANT INC 196 BOSTON AVE SUITE 2800 MEDFORD MA 02155
Business Address
PERRY MICHAEL S (Reporting) CIK: 0001250379 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 191089336